Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery

Last updated: January 13, 2025
Sponsor: McGill University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Resistance exercise

Ketone Monoester + Whey Protein (KET+PRO)

Whey Protein (PRO)

Clinical Study ID

NCT06769100
A00-M15-24A
  • Ages 18-40
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

An acute bout of resistance exercise stimulates muscle protein synthesis (MPS) rates for up to 24-48 hours, supporting muscle growth and repair. To optimize the anabolic effects of resistance exercise, the provision of dietary amino acids (i.e., proteins) is essential. Dietary protein intake provides the body with necessary amounts of essential and non-essential amino acids, which represent the building blocks for muscle proteins, enhancing anabolic muscle growth. The ingestion of dietary protein, such as whey protein, is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle following resistance exercise. Research has demonstrated a dose-dependent relationship between protein intake and MPS rate, with 25 grams being the optimal dose to maximally stimulate MPS rates in younger adults with excess protein oxidized as a fuel source.

Determining whether this maximally stimulated MPS response can be further heightened during post-exercise recovery using non-protein dietary factors is yet to be explored. Recently, it has been shown that novel orally ingested ketone body supplements can stimulate MPS rates in younger adults at rest.

Ketone bodies (β-OHB) are lipid- derived molecules normally produced under conditions of glucose deprivation (i.e., fasting/starvation, or a low carbohydrate 'ketogenic' diet). However, these orally ingested ketone supplements rapidly increase blood ketone levels without the need for dietary restriction6. In vitro research showed that the combination of leucine and ketone bodies stimulated a 2-fold increase in MPS, compared to the leucine group alone, indicating synergistic effects of protein and ketone bodies on MPS. However, the effect of ketone supplementation, with and without dietary protein co-ingestion, on MPS rate during post-exercise recovery is yet to be investigated. If ketone bodies can amplify the anabolic response to dietary protein, they may provide a novel approach to maximizing muscle adaptation during post-exercise recovery.

Therefore, the purpose of this study is to evaluate the effects of ketone monoester intake on postprandial muscle protein synthesis rates when consumed alone and when co-ingested with an optimal dose (25 g) of whey protein during recovery after resistance exercise compared to 1) an optimal dose of whey protein (25 g), and 2) a control flavored water. It is hypothesized that muscle protein synthesis rates will be stimulated following the ingestion of the ketone body beverage. Further, muscle protein synthesis rates will be further enhanced when the ketone-containing beverage and an optimal dose are taken together.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy adult female or male participants who are 18-40 years of age (inclusive) BMI >18.5 and <30.0 kg/m2

  • Moderately active (i.e., ≥ 1 session of lower-body weightlifting /week for theprevious 2 months).

  • Has maintained stable use of medication and supplements (which are not limited bythe exclusion criteria), stable dietary and lifestyle habits, and stable bodyweight, for the last 3 months prior to screening and agree to maintain themthroughout the study.

  • Be willing to entirely avoid alcohol consumption 48hr prior to the experimental testday.

  • Willing and able to agree to the requirements and restrictions of this study, bewilling to give voluntary consent, be able to understand and read thequestionnaires, and carry out all study-related procedures.

Exclusion

Exclusion Criteria:

  • Females who are lactating or pregnant

  • Females using third-generation oral contraceptives (including: Desogen®, Ortho-Cept,Ortho-Cyclen, Ortho Tri-Cyclen) as these are known to affect protein metabolism infemales.

  • Individuals with metabolic disorders including: Type I or Type II diabetes

  • Individuals with a history of thrombosis / cardiovascular disease

  • Individuals who use of anticoagulants

  • Individuals with musculoskeletal / orthopedic disorders

  • Individuals with knee injuries (i.e., ACL injuries).

  • Individuals who have used tobacco products within the last 6 months

  • Individuals with a history of neuromuscular problems

  • Chronic usage of medications known to modulate skeletal muscle metabolism (i.e.corticosteroids, hormone replacement therapy (HRT), and over-the-counter supplementsincluding creatine monohydrate) in the last 6 months.

  • Individuals with allergies to milk proteins (whey or casein).

  • Individuals with lactose intolerance

  • Individuals with Phenylketonuria (PKU)

  • Previous participation in amino acid tracer studies.

  • Adherence to a vegetarian or vegan diet

  • Current use of ketone supplements or adherence to a ketogenic diet

  • Individuals who train more than ≥ 5 sessions of lower-body weightlifting /week forthe previous 4 months

Study Design

Total Participants: 48
Treatment Group(s): 5
Primary Treatment: Resistance exercise
Phase:
Study Start date:
January 10, 2025
Estimated Completion Date:
October 30, 2025

Study Description

A parallel group design will be used for this randomized double-blind, placebo-controlled study in healthy adults to investigate the effects of ketone monoester on myofibrillar protein synthesis rates during post-exercise recovery. There are 4 groups in this trial, including one ketone group (0.36g/kg body weight) (KET), one protein group (25 g whey protein) (PRO), a combination of ketone and protein (KET+PRO), and a placebo group (flavoured water) (CON). A total of 48 participants will be enrolled in this trial (n=12 per group).

The study will include a screening visit (visit 1), 10-repetition maximum (10-RM) testing (visit 2), where participants' 10-RM will be determined for the exercise protocol, and the experimental trial (visit 3).

During the experimental trials, participants will arrive to the laboratory in a fasted state, and a prime dose of the L-[ring-2H5]-phenylalanine will be administered followed by a continuous infusion at a rate 0.05 μmol/kg of body weight/min. Then, participants will perform a unilateral lower-body resistance exercise, consisting of 8 sets of 10 reps of unilateral leg extension at 90% of their 10-RM with 90 seconds rest in between sets. Following exercise, the nutritional treatment will be administered.

Arterialized blood will be collected at baseline and 13 postprandial timepoints across 9 hours for plasma amino acid, glucose, and insulin quantitation.

Additionally, changes in capillary blood β-HB concentration will be assessed throughout the trial by collecting capillary blood samples at baseline and 10 postprandial timepoints. Finally, muscle biopsy samples from both the exercised leg and the rested leg will be collected prior to beverage intake and at the 5-hour mark of the postprandial post-recovery period to assess myofibrillar protein synthesis rates.

Connect with a study center

  • McGill University

    Montreal, Quebec H2W 1S4
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.